07:00 , Apr 28, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: microRNA-3188 (MIR3188); forkhead box O1 (FOXO1)

Cancer INDICATION: Nasopharyngeal cancer Patient sample, cell culture and mouse studies suggest promoting expression of MIR3188 or FOXO1 could help treat nasopharyngeal carcinoma (NPC). In patients, low tumor levels of MIR3188 correlated with large tumor volume and...